Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 22224474)

1.

The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.

Berger J, Stirnemann J, Bourgne C, Pereira B, Pigeon P, Heraoui D, Froissart R, Rapatel C, Rose C, Belmatoug N, Berger MG.

Br J Haematol. 2012 Apr;157(2):274-7. doi: 10.1111/j.1365-2141.2011.08989.x. Epub 2012 Jan 9. No abstract available.

PMID:
22224474
2.

Early access experience with VPRIV(®): recommendations for 'core data' collection.

Hughes DA, Al-Sayed M, Belmatoug N, Bodamer O, Böttcher T, Cappellini M, Cohen IJ, Eagleton T, Elstein D, Giraldo P, Jones S, Kaplinsky C, Lund A, Machaczka M, Mengel E, Pastores GM, Rosenbaum H, Sjo M, Tiling N, Tsaftaridis P, Zimran A, Weinreb N.

Blood Cells Mol Dis. 2011 Aug 15;47(2):140-2. doi: 10.1016/j.bcmd.2010.10.015. Epub 2010 Dec 13. No abstract available.

PMID:
21146428
3.

Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease.

Elstein D, Cohn GM, Wang N, Djordjevic M, Brutaru C, Zimran A.

Blood Cells Mol Dis. 2011 Jan 15;46(1):119-23. doi: 10.1016/j.bcmd.2010.07.008. Epub 2010 Aug 19.

PMID:
20727796
4.

Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India.

Nagral A, Mewawalla P, Jagadeesh S, Kabra M, Phadke SR, Verma IC, Puri RD, Gupta N, Kishnani PS, Mistry PK.

Indian Pediatr. 2011 Oct;48(10):779-84.

PMID:
22080680
6.

Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.

Camou F, Viallard JF.

Blood Cells Mol Dis. 2012 Jan 15;48(1):51-2. doi: 10.1016/j.bcmd.2011.09.005. Epub 2011 Oct 7. No abstract available.

PMID:
21983348
7.
8.

[A retrospective study on enzyme replacement therapy in patients with Gaucher disease].

Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.

Zhonghua Er Ke Za Zhi. 2006 Sep;44(9):653-6. Chinese.

PMID:
17217655
9.

Competing for the treasure in exceptions.

Cox TM.

Am J Hematol. 2013 Mar;88(3):163-5. doi: 10.1002/ajh.23399. Epub 2013 Feb 9. No abstract available.

PMID:
23400870
10.

Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease.

Arıkan-Ayyıldız Z, Yuce A, Uslu-Kızılkan N, Demir H, Gurakan F.

Pediatr Blood Cancer. 2011 Apr;56(4):664-6. doi: 10.1002/pbc.22863. Epub 2010 Dec 15.

PMID:
21298757
11.

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease.

den Bakker MA, Grünberg K, Boonstra A, van Hal PT, Hollak CE.

Histopathology. 2012 Aug;61(2):324-6. doi: 10.1111/j.1365-2559.2012.04261.x. Epub 2012 Jun 13. No abstract available.

PMID:
22690977
12.

Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction.

Elstein D, Foldes AJ, Zahrieh D, Cohn GM, Djordjevic M, Brutaru C, Zimran A.

Blood Cells Mol Dis. 2011 Jun 15;47(1):56-61. doi: 10.1016/j.bcmd.2011.04.005. Epub 2011 May 4.

PMID:
21536468
13.

Gaucher disease.

Mignot C, Gelot A, De Villemeur TB.

Handb Clin Neurol. 2013;113:1709-15. doi: 10.1016/B978-0-444-59565-2.00040-X. Review.

PMID:
23622393
14.

Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.

Rudzki Z, Okoń K, Machaczka M, Rucińska M, Papla B, Skotnicki AB.

Eur J Haematol. 2003 May;70(5):273-81.

PMID:
12694162
15.

Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy.

Elstein D, Abrahamov A, Altarescu G, Zimran A.

Blood Cells Mol Dis. 2013 Feb;50(2):140. doi: 10.1016/j.bcmd.2012.09.008. Epub 2012 Oct 22. No abstract available.

PMID:
23085428
16.

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014.

Barranger JA, Brady RO, Grabowski GA, Mankin H, Mistry PK, Weinreb NJ.

Am J Hematol. 2014 May;89(5):457-8. doi: 10.1002/ajh.23687. Epub 2014 Mar 7. No abstract available.

PMID:
24488939
17.

MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy.

Hill SC, Parker CC, Brady RO, Barton NW.

J Comput Assist Tomogr. 1993 Sep-Oct;17(5):806-9.

PMID:
8370839
18.

Glucocerebroside storage in normal monocyte cultures.

Hardy B, Teitelman-Weissman B, Chazan S, Neri A.

Biomed Pharmacother. 1987;41(1):40-4.

PMID:
3607254
19.

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report.

Martinez-Redondo C, Ortuño FJ, Lozano ML, Jerez A, del Mar Osma M, Giraldo P, Vicente V.

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S265-7. doi: 10.1007/s10545-009-1207-8. Epub 2009 Jun 27.

PMID:
19562501
20.

[Molecular basis of treatment in Gaucher's disease].

Pocoví M.

Med Clin (Barc). 2011 Sep;137 Suppl 1:32-8. doi: 10.1016/S0025-7753(11)70014-8. Spanish.

PMID:
22230123
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk